Humacyte
HUMA
Humacyte (HUMA) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Benchmark | Maintained | Speculative Buy | $1.00 from $2.00 | Aug 13, 2026 |
| BTIG | Maintained | Buy | $2.00 | Jul 28, 2026 |
| TD Cowen | Maintained | Buy | $1.25 from $1.50 | Jun 17, 2026 |
| BTIG | Maintained | Buy | $2.00 | Jun 16, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 from $3.00 | Jun 11, 2026 |
| BTIG | Maintained | Buy | $2.00 | Jun 8, 2026 |
| Benchmark | Maintained | Speculative Buy | $2.00 from $1.00 | Jun 1, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | May 26, 2026 |
| TD Cowen | Maintained | Buy | $1.50 from $1.00 | May 14, 2026 |
| BTIG | Maintained | Buy | $2.00 from $3.00 | May 13, 2026 |
| BTIG | Maintained | Buy | $3.00 | Apr 28, 2026 |
| D. Boral Capital | Maintained | Buy | $25.00 | Apr 28, 2026 |
| D. Boral Capital | Maintained | Buy | $25.00 | Apr 24, 2026 |
| D. Boral Capital | Maintained | Buy | $25.00 | Apr 21, 2026 |
| Barclays | Maintained | Overweight | $1.50 from $3.50 | Apr 8, 2026 |
| Benchmark | Downgraded | Buy → Speculative Buy | $1.00 from $10.00 | Mar 31, 2026 |
| TD Cowen | Maintained | Buy | $1.00 from $3.50 | Mar 30, 2026 |
| Piper Sandler | Maintained | Neutral | $1.00 from $3.00 | Mar 30, 2026 |
| BTIG | Maintained | Buy | $3.00 from $6.00 | Mar 27, 2026 |
| D. Boral Capital | Maintained | Buy | $25.00 | Mar 27, 2026 |
Frequently asked questions
What is the latest analyst rating on HUMA?
On Aug 13, 2026, Benchmark maintained Humacyte at Speculative Buy with a price target of $1.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.